Browse > Article
http://dx.doi.org/10.13048/jkm.17007

Correlation Analysis of Organic Acid Comprehensive Profile Markers with Chemotherapy Induced Peripheral Neuropathy in Cancer Patients  

Park, Ji Hye (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University)
Sung, Simon SangYup (SUNIN BIO)
Lee, Jin Sun (Department of surgery, Chungnam National University Hospital)
Yoo, Hwa Seung (East West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University)
Publication Information
The Journal of Korean Medicine / v.38, no.1, 2017 , pp. 72-80 More about this Journal
Abstract
Objectives: The purpose of this study is to evaluate the urinary organic acid comprehensive profile for chemotherapy induced peripheral neuropathy (CIPN). Methods: Participants are 66 patients with CIPN who had symptom (Visual analog scale ${\geq}30mm$, Eastern Cooperative Oncology Group ${\leq}2$). Participants were tested with organic acid comprehensive profile markers. Results: Positive Correlation was observed in the neurotransmitter metabolism markers, N-methyl-D-aspartate (NMDA) modulators markers, detoxification markers, energy production markers, amino acid metabolism markers, and intestinal dysbiosis markers. Especially, all the neurotransmitter metabolism markers were showed positive rate of 44%. In addition, neuro-endo-immune was associated with energy metabolism (mitochondrial dysfunction) in CIPN of cancer patient. especially detoxification, intestinal bacterial hyperplasia, vitamin deficiency (folate, complex B group, vitamin C). Conclusions: Significant urinary organic acid comprehensive profile results were obtained in cancer patients who induced peripheral neuropathy by chemotherapy.
Keywords
Chemotherapy induced peripheral neuropathy; Urinary organic acid; Neurotransmitter metabolism; Bio markers;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Tofthagen CS, McMillan SC, Kip KE. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool. Cancer Nurs. 2011;34(4):E10-20.   DOI
2 Choie MH, Jeong IS, Jeong TY, Kim KS, Yoo HS. Effects of reflexology foot massage to improve quality of life and reduce anxiety for hospitalized cancer patients undergoing chemotherapy or radioisotope therapy. J Korean Trad Oncol. 2009;14:61-74.
3 Windebank AJ, Grisold W. Chemotherapy -induced neuropathy. J Peripher Nerv Syst. 2008;13(1):27-46.   DOI
4 Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. European journal of cancer. 2008;44(11):1507-15.   DOI
5 Housheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Emin Oncol. 2006;33; 15-49.
6 Ajani JA, Welch SR, Raber MN, Fields WS, Krakoff IH. Comprehensive criteria for assessing therapy-induced toxicity. Cancer Invest. 1990;8:147-59.   DOI
7 Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207-14.   DOI
8 Usha KM, Jayantee K, Pradeep PN. Diagnostic approach to peripheral neuropathy. Ann Indian Acad Neurol. 2008;11(2):89-97.   DOI
9 Available at: URL: http://www.questdiagnostics.com/testcenter/testguide.action?dc=WP_LabDiagnosis_PeripheralNeurop#ImmuneMediatedPeripheralNeuropathies.
10 Thomas N. Seyfried, Roberto E. Flores, Angela M. Poff, Dominic P.D'Agostino. Cancer as a Metabolic Disease. Carcinogenesis. 2014;35(3):515-27.   DOI
11 Lord RS, Bralley JA. Laboratory evaluations for integrative and functional medicine. Duluth. GA:Metametrix Institute. 2008.
12 Orgacka h, Zbytniewski Z. Excretion of vanillic acid and homovanillic acid and tissue distribution of catecholamines and their metabolites in mice with various levels of pigmentation. Endocrinol Pol. 1991;42(3):471-9.
13 Berger T, Malayeri R, Doppelbauer A, Krajnik G, Huber H, Auff E, et al. Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy. Eur J Cancer. 1997;33(9):1393-9.   DOI
14 Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5:649-55.   DOI
15 Cavaletti G, Jann S, Pace A, Plasmati R, Siciliano G, Briani C, et al. Multi-center assessment of he Total Neuropathy Score for chemotherapy-induced peripheral eurotoxicity. J Peripher Nerv Syst. 2006;11:135-41.   DOI
16 Kwak MK, Kim EJ, Lee ER, Kwon IG, Hwang MS. Characteristics and Quality of Life in Patients with Chemotherapy-Induced Peripheral Neuropathy. Journal of Korean oncology nursing. 2010;10(2):231-9.   DOI
17 Forsyth PA, Balmaceda C, Peterson K, Seidman AD, Brasher P, DeAngelis LM, et al. Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. J Neurooncol. 1997;35(1):47-53.   DOI
18 Du Bois A, Schlaich M, Luck HJ, Mollenkopf A, Wechsel U, Rauchholz M, et al. Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy. Support Care Cancer. 1999;7(5):354-61.   DOI
19 Kim JH, Choi KS, Kim TW, Hong YS. Quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy. Asian Oncology Nursing. 2011;11(3):254-62.   DOI
20 Kim HY, Kang JH, Youn HJ, So HS, Song CE, Chae SY, et al. Reliability and validty of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire to assess chemotherapy-induced peripheral neuropathy. J Korean Acad Nurs. 2014;44(6):735-42.   DOI